- CSL Receives Positive CHMP Opinion for Etranacogene Dezaparvovec – Gene Therapy for Adults with Hemophilia B.
Positive CHMP Opinion for Etranacogene Dezaparvovec
Regulatory milestone moves CSL one step closer to bringing the promise of gene therapy for hemophilia B to patients in Europe